Medline Inc. Class A Common Stock (MDLN) Stock Forecast & Price Target
Medline Inc. Class A Common Stock · NASDAQ
$40.51+0.81 (+2.04%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 24 firms covering Medline Inc. Class A Common Stock, 20 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $40.00 to $62.00, a moderate spread. The average target of $50.43 sits 24% above the current $40.51. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.39 next quarter toward $1.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS24 ratings
Moderate Buy
Strong Buy00%
Buy2083%
Hold417%
Sell00%
Strong Sell00%
Based on 24 analysts giving stock ratings to Medline Inc. Class A Common Stock.
As of Jul, 20 of 24 firms rate MDLN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MDLN EPS & revenue forecast
EPS · NEXT QUARTER
$0.39
Range $0.36 – $0.43 · 20 analysts
Next period, 20 analysts expect Medline Inc. Class A Common Stock to earn $0.39 a share (range $0.36 – $0.43), versus — a year earlier. Full-year consensus is $1.51, growing to $1.67 the year after.
REVENUE · NEXT QUARTER
$7.7B
Range $7.7B – $7.8B · 20 analysts
Revenue is expected to reach $7.7B (range $7.7B – $7.8B). Full-year consensus is $31.1B, rising to $35.0B next year.
Top analysts covering Medline Inc. Class A Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDLN.
#1
Patrick Donnelly
Citigroup · Rank #260
Buy
$55.00+35.8% to target
Overall win rate
32%
+ Follow
#2
Jason Bednar
Piper Sandler · Rank #303
Buy
$55.00+35.8% to target
Overall win rate
33%
+ Follow
#3
David Larsen
BTIG
Buy
$55.00+35.8% to target
Coverage
—
+ Follow
#4
GS
Glen Santangelo
Barclays
Buy
$45.00+11.1% to target
Coverage
—
+ Follow
#5
Ivan Feinseth
Tigress Financial
Buy
$62.00+53.0% to target
Coverage
—
+ Follow
MDLN stock forecast FAQ
What is MDLN's average 12-month price target?+
The 21 analysts with a live target average $50.43 for Medline Inc. Class A Common Stock over the next 12 months, ranging from a $62.00 high to a $40.00 low.
Is MDLN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 24 analyst ratings, 20 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MDLN?+
The Street-high target is $62.00 (Tigress Financial), and the Street-low is $40.00 (BNP Paribas). The average of all 21 active targets is $50.43.
How many Wall Street analysts cover MDLN?+
24 analysts have an active rating on Medline Inc. Class A Common Stock, and 21 firms carry a live 12-month price target.
Who is the most accurate analyst covering MDLN?+
Among analysts who currently cover MDLN, Patrick Donnelly of Citigroup has the strongest overall Quantellect track record (Rank #260). Their current call is Buy with a $55.00 target.
What is Medline Inc. Class A Common Stock's projected EPS for next quarter?+
The consensus estimate is $0.39 per share (range $0.36 – $0.43) across 20 analysts. Full-year EPS is projected at $1.51, rising to $1.67 the following year.
How much revenue is Medline Inc. Class A Common Stock expected to report next quarter?+
Consensus revenue is $7.7B (range $7.7B – $7.8B). Full-year revenue is projected at $31.1B, growing to $35.0B next year.
Have analysts been upgrading or downgrading MDLN lately?+
As of Jul, 20 of 24 firms rate MDLN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDLN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
